--- title: 'Contract Recruiting Coordinator at Genesis Molecular AI' canonical: 'https://feeny.ai/job/contract-recruiting-coordinator-genesis-molecular-ai-new-york-jp3t2jz8ff95' type: 'job' last_seen: '2026-09-07' --- # Contract Recruiting Coordinator at Genesis Molecular AI - **Company:** Genesis Molecular AI - **Location:** New York, NY / San Francisco, CA - **Employment:** contract - **Work type:** hybrid - **Posted:** 2026-09-04 - **Last confirmed live:** 2026-09-07 - **Apply:** https://jobs.ashbyhq.com/genesis-molecular-ai/444cab8f-fdbf-44a4-a900-af7cf710478d ## Job description Accepting applications until Friday, September 11. ## About the Role We're looking for a Contract Talent Coordinator to help ensure our candidate and employee experience is top-notch. This is a 6-month (20 hours per week) contract with the possibility of extension based on business needs. The ideal candidate is well-versed in day-to-day Talent Acquisition coordination, able to autonomously plan efficient processes, and proactive about finding new ways to do the job better. They thrive in a fast-paced, innovative, and collaborative startup environment, bringing exceptional follow-through, a strong sense of urgency, and precision to everything they do. If this sounds like you, we encourage you to apply! You Will - Support a world-class candidate experience from interview scheduling to onboarding - Liaise with our executive admin team to help connect candidates with our leadership team - Own the scheduling process end-to-end for both evergreen and opportunistic hiring needs, proactively anticipating and surfacing needs and obstacles - Coordinate on-site interviews and candidate visits, including logistics, travel, and day-of support - Use our recruiting tech stack, including Ashby, to help teams streamline processes and delight candidates and stakeholders - Manage clear, concise, and professional communication with candidates and hiring partners, in written and verbal form - Maintain confidential candidate and employee data - Respond to internal and external inquiries or requests and provide assistance in a timely manner, while optimizing for speed and efficiency You Have - Bachelor's degree in business administration or a related field - Minimum 1 year of experience in Talent Acquisition operations; 2-3 years preferred - Prior experience in a fast-paced tech company preferred - Experience supporting technical teams is a huge plus - Excellent communication, organizational, and multitasking skills - Passionate about building and growing relationships - Track record of supporting multiple scheduling or customer needs at once with a high level of speed and accuracy - A keen eye for detail and the ability to continuously improve and streamline processes - Ability to keep and handle confidential information appropriately - Fast learner with a growth mindset who thrives in a constantly evolving environment with shifting priorities, while maintaining a get-it-done attitude - Proficient in MS Office and/or Google Suite; familiarity with Ashby a plus ## About Genesis Molecular AI Genesis Molecular AI http://genesis.ml is pioneering foundation models for molecular AI to unlock a new era of drug design and development. Our generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl https://www.businesswire.com/news/home/20251028030745/en/Genesis-Molecular-AI-Unveils-Pearl-a-Field-Leading-Foundation-Model-that-Achieves-Unprecedented-Performance-in-Drug-Protein-Structure-Prediction for structure prediction. Genesis is backed by premier AI and life science investors, including a16z, NVIDIA, Rock Springs Capital, Menlo Ventures, T. Rowe Price, Fidelity, and Radical Ventures. Genesis has also signed category-leading AI-pharma deals, the most recent of which was a significant expansion with Incyte (see coverage in Forbes https://www.forbes.com/sites/innovationrx/2026/05/20/inside-incytes-120-million-ai-for-drug-development-deal/ and GEN https://www.genengnews.com/topics/artificial-intelligence/small-molecules-to-big-partnership-incyte-genesis-expand-ai-collaboration-to-1b/) with a total potential deal value of several billion dollars. Genesis is headquartered in San Mateo, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer. ## About Genesis Molecular AI ## Company Overview - **One-liner**: Genesis Molecular AI combines frontier AI research with deep drug discovery expertise to develop a proprietary platform (GEMS) that accelerates the design and optimization of small molecule medicines. - **Entity Type**: Private (Series B; raised over $300M in total funding) - **Headquarters**: Burlingame, California, United States (with a fully integrated laboratory in San Diego and offices in New York) - **Founded**: Not publicly disclosed (first major funding round – $200M Series B – closed in 2023) - **Founders**: Evan Feinberg Ph.D. (CEO, Co-founder) and Sergey Edunov (Co-founder); other key leaders include Will McCarthy (CTO) and Shifeng Pan Ph.D. (COO) ## Core Business - **Primary Industry**: Biotechnology – AI-powered small molecule drug discovery. - **Target Customers**: Large pharmaceutical partners (B2B) via platform collaborations, plus an internal pipeline of wholly owned drug programs. - **Mission/Purpose**: “Solving the hardest problems in drug discovery to change the landscape of medicine” by creating and scaling domain-specific AI models that integrate physics, chemistry, biology, and software. ## Products & Services - **[GEMS Platform](https://www.genesis.ml/)**: An AI operating system for molecular design. GEMS (Genesis Exploration of Molecular Space) integrates generative and predictive models to accelerate hit identification, lead optimization, and candidate selection. It is deployed for internal pipeline programs and major pharma collaborations. - **[Pearl Foundation Model](https://www.genesis.ml/about)**: A generative foundation model for biomolecular structure prediction (protein-ligand) that demonstrated field-leading performance. Built in collaboration with NVIDIA and trained on large-scale synthetic data. - **Internal Drug Pipeline**: Small molecule inhibitors targeting oncology (e.g., pan-mutant allosteric PIK3CA inhibitors) and immunology (e.g., inflammatory signaling pathways). Programs are in discovery stage approaching development candidate nomination. - **Platform Partnership Model**: “Forward-deployed engineers and scientists” work alongside pharma partners (Gilead, Incyte) to apply GEMS to their targets, with deal structures that include upfront payments, milestones, and data sharing that feeds back into model training. ## Market Standing - **Valuation/Market Cap**: Not disclosed. - **Key Metric**: Total funding raised >$300M (including $200M Series B in 2023 co-led by a16z, with participation from Fidelity, BlackRock, NVIDIA’s NVentures, Rock Springs Capital, T. Rowe Price, Radical Ventures, Menlo Ventures). - **Notable Investors/Partners**: Andreessen Horowitz, Fidelity, BlackRock, NVIDIA (NVentures), Rock Springs Capital, T. Rowe Price, Radical Ventures, Menlo Ventures. Pharma partners: Gilead ($35M upfront, 2024), Incyte ($150M total upfront including equity investment, 2025–2026). - **Growth Signals**: 125 employees (+26.4% YoY); operates in 7 countries; LinkedIn following grew 41.9% in the past year; Pearl model launched to strong benchmarking results; Incyte expanded collaboration with at least 5 additional targets and data for model training. ## Competitive Advantages - **Integration of disciplines**: The company pairs leading AI researchers with world-class drug hunters, co-creating models and medicines in iterative loops. - **Wet-lab flywheel**: In-house lab in San Diego generates experimental data that closes the loop for model training, prediction, and validation – a virtuous cycle that strengthens the platform with every program. - **Partnership data advantage**: Deals with Gilead and Incyte provide significant proprietary experimental data (e.g., Incyte data for training GEMS), creating a moat that is hard for pure-play AI companies to replicate. - **Domain-specific foundation models**: Models like Pearl are purpose-built for small molecule drug discovery, unlike general-purpose generative AI. ## Strategic Focus - **Advancing internal pipeline**: Moving lead programs in oncology (PIK3CA, apoptosis) and immunology toward development candidate nomination. - **Scaling platform partnerships**: Expanding existing collaborations and signing new ones to broaden the impact of GEMS and generate more training data. - **Continuous model improvement**: Investing in next-generation foundation models (e.g., Pearl) and leveraging partner data to stay at the frontier of molecular AI. - **Hiring across AI and drug discovery**: Open roles for machine learning research scientists, software engineers, computational chemists, medicinal chemists, and biologists indicate a focus on scaling both the tech and biology teams. ## Why Work Here - **Culture**: Described as a “meritocracy of ideas” where the strongest ideas win through evidence and reasoning, not hierarchy. Values include ownership, experimentation, candor with kindness, curiosity, and collaboration across disciplines. - **Work Environment**: Flexible work environment with offices in Burlingame, San Diego, and New York. Daily meals and snacks provided in the office. Ergonomic consulting and equipment available. - **Compensation & Benefits**: Highly competitive compensation including base salary, bonus, and equity. Comprehensive health, dental, and vision insurance. Open PTO policy, parental leave, 401(k) retirement savings, financial planning resources. - **Impact**: Employees work on some of the hardest problems in drug discovery – applying cutting-edge AI to targets that are canonically undruggable, with the potential to create new treatment options for severe diseases. - **Team Composition**: The company actively hires across AI research, software engineering, molecular simulation, and drug discovery disciplines, fostering an interdisciplinary environment where researchers and drug hunters co-create daily. ## Sources 1. [genesis.ml](https://www.genesis.ml/) 2. [genesis.ml/about](https://www.genesis.ml/about) 3. [genesis.ml/careers](https://www.genesis.ml/careers) 4. [genesis.ml/partners-pipeline](https://www.genesis.ml/partners-pipeline) 5. [LinkedIn - Genesis Molecular AI](https://www.linkedin.com/company/genesis-molecular-ai) ## Other roles at Genesis Molecular AI - [Manager, New Product Planning](https://feeny.ai/job/manager-new-product-planning-genesis-molecular-ai-san-diego-s9gybtg3hfg8) — San Diego, CA - [ML & Molecular Simulation Scientist](https://feeny.ai/job/ml-molecular-simulation-scientist-genesis-molecular-ai-san-mateo-z7qx94p0vrzb) — San Mateo, CA - [Applied ML Scientist (Staff / Principal)](https://feeny.ai/job/applied-ml-scientist-staff-principal-genesis-molecular-ai-san-mateo-ypytjf6pxab2) — San Mateo, CA - [Staff Technical Recruiter](https://feeny.ai/job/staff-technical-recruiter-genesis-molecular-ai-san-mateo-t76m4py49wex) — San Mateo, CA - [Fullstack Software Engineer (Senior / Staff)](https://feeny.ai/job/fullstack-software-engineer-senior-staff-genesis-molecular-ai-san-mateo-pap6516adm11) — San Mateo, CA - [Software Engineer - Core Infrastructure](https://feeny.ai/job/software-engineer-core-infrastructure-genesis-molecular-ai-san-mateo-sgbtcj4j76d4) — San Mateo, CA - [Machine Learning Infrastructure Engineer](https://feeny.ai/job/machine-learning-infrastructure-engineer-genesis-molecular-ai-san-mateo-a012z1zdp33y) — San Mateo, CA - [Product Management Lead](https://feeny.ai/job/product-management-lead-genesis-molecular-ai-san-mateo-qv16q5s8c4q2) — San Mateo, CA - [ML Research Scientist, Foundation Models (Senior / Staff / Principal)](https://feeny.ai/job/ml-research-scientist-foundation-models-senior-staff-principal-genesis-gnpr61e1bf7n) — San Mateo, CA - [ML Research Engineer, Foundation Models (Senior / Staff / Principal)](https://feeny.ai/job/ml-research-engineer-foundation-models-senior-staff-principal-genesis-molecular-7ky449yvkh2y) — San Mateo, CA